Peer-reviewed epidemiology journal articles 2006

Wednesday 20 December, 2006

Refereed publications 2006:

  1. Aden KKH, Baglietto L, Baffoe-Bonnie A, Coebergh JWW, Bailey-Wilson JE, Trink B, Verbeek ALM, Schoenberg MP, Witjes JA, Kiemeney LA. Segregation analysis of urothelial cell carcinoma. Eur J Cancer. 2006 July;42:1428-1433.
  2. Aghmesheh M, Suo Z, Friedlander M, Nesland JM, Kaern J, Stewart M, KConfab, Dorum A, Tucker KM, Buckley MF. Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas. Pathology. 2006 Apr;38(2):145-51
  3. Alsop K, Mead L, Smith D, Royce SG, Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, Hopper JL, Southey MC. Low somatic K-RAS mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer. 2006 Jul;42(10):1357-61
  4. Asia Pacific Cohort Studies Collaboration, Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, Gu DF, Woodward M. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control 2006;15:181-8.
  5. Asia Pacific Cohort Studies Collaboration. An evaluation of metabolic risks for coronary death in the Asia Pacific Region. Diabetes Research and Clinical Practice 74(2006); 274-281.
  6. Asia Pacific Cohort Studies Collaboration. Central obesity and cardiovascular in the Asia Pacific region. Asia Pac J Clin Nutrition 2006; 15(3): 287-292.
  7. Asia Pacific Cohort Studies Collaboration. Coronary risk prediction for those with and without diabetes. Eur J Cardiovasc Prev Rehabil. 2006;13(1):30-36.
  8. Asia Pacific Cohort Studies Collaboration. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006 Jan 14;332(7533):73-8.
  9. Asia Pacific Cohort Studies Collaboration. Central obesity and cardiovascular disease in the Asia Pacific region. Asia Pac J Clin Nutri. 2006;15:287-92.
  10. Asia Pacific Cohort Studies Collaboration. Body mass index and the risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr. 2006;15:127-33.
  11. Asia Pacific Cohort Studies Collaboration. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tobacco Control 2006 Jun;15(3):181-8.
  12. Asia Pacific Cohort Studies Collaboration. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-pacific region. Cancer Epidemiol Biomakers Prev 2006; 15:2435-40.
  13. Asia Pacific Cohort Studies Collaboration. An evaluation of metabolic risks for coronary death in the Asia Pacific region. Diabetes Res Clin Pract. 2006;74:7274-81.
  14. Asia Pacific Cohort Studies Collaboration. Coronary risk prediction among individuals with and without diabetes. Eur J Cardiov Prev Rehab. 2006;13:30-6.
  15. Asia Pacific Cohort Studies Collaboration. The impact of cardiovascular risk factors on the age related excess risk of coronary heart disease. Int J Epidemiol. 2006;35:1025-33.
  16. Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol. 2006 Nov;142(11):1422-7
  17. Baglietto L, English DR, Hopper JL, Powles J, Giles GG. Average volume of alcohol consumed, type of beverage, drinking pattern and the risk of death from all causes. Alcohol Alcohol. 2006 Nov-Dec;41(6):664-71.
  18. Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, Hopper JL. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006 Feb;59(2):114-124.
  19. Baglietto L, Severi G, English DR, Hopper JL, Giles GG. Alcohol consumption and prostate cancer risk: Results from the Melbourne Collaborative Cohort Study. Int J Cancer 2006 Apr;119(6):1501-4.
  20. Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H; kConFab Investigators; Kirk JA. Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology. 2006 Nov;49(5):523-32.
  21. Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat. 2006 Nov;27(11):1122-8
  22. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006 Sep;7(9):766-74. Review.
  23. Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006 Oct;42(15):2463-71. Epub 2006 Sep 1.
  24. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM, Russell PJ, Giles GG, Breit SN. Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis. Clin Cancer Res. 2006 Jan 1;12(1):89-96
  25. Cazzaniga M, Severi G, Casadio C, Chiapparini L, Veronesi U, Decensi A. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1311-5.
  26. Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, Scholl T, Bekessy A, Marsh A, Lovelock P, Wong M, Tesoriero A, Renard H, Southey M, Hopper JL, Yannoukakos K, Brown M, Easton D, Tavtigian SV, Goldgar D, Spurdle AB; kConFab Investigators. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res. 2006 Feb 15;66(4):2019-27.
  27. Colombo N, Formelli F, Cantu MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, et al. A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1914-9.
  28. Creamer MC, Carboon I, Forbes AB, McKenzie DP, McFarlane AC, Kelsall HL, Sim MR. Psychiatric disorder and separation from military service: A 10 year retrospective study. American Journal of Psychiatry 2006; 163:733-734.
  29. Dite GS, Wark JD, Giles GG, English DR, McCredie MRE, Hopper JL. Is there a positive association between mammographic density and bone mineral density? Breast Cancer Research 2006, 8:401. Epub 2006 Feb 13.
  30. El Haber N, Hill KD, Cassano AM, Paton LM, MacInnis RJ, Cui JS, Hopper JL, Wark JD. Genetic and environmental influences on variation in balance performance among female twin pairs aged 21-82 years. Am J Epidemiol. 2006 Aug 1;164(3):246-56
  31. English DR, Milne E, Simpson JA. Ultraviolet radiation at places of residence and the development of melanocytic nevi in children. Cancer Causes &Control 2006;Feb;17(1):103-7.
  32. Farshid G, Balleine RL, Cummings M, Waring P; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol. 2006 Nov;30(11):1357-66.
  33. Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG. Hormone therapy and breast cancer: what factors modify the association? Menopause. 2006 March/April;13(2):178-184.
  34. Giles GG, Simpson J, English DR, Hodge AM, Gertig D, MacInnis R, Hopper J. Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer. Int J Cancer. 2006 Apr 1;118(7):1843-7.
  35. Glass DC, Sim MR, Kelsall HL, Ikin JF, McKenzie D, Forbes A, Ittak P. What was different about exposures reported by male Australian Gulf War veterans during the 1991 Persian Gulf War, compared with exposures reported for other deployments? Military Medicine 2006; 171:632-638.
  36. Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G. Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol. 2006 Mar;27(1):42-5.
  37. Guzzi G, Minoia C, Pigatto PD, Severi G. Methylmercury, amalgams, and children's health. Environ Health Perspect. 2006 Mar;114(3):A149; author reply A149-50.
  38. Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, kConFab Investigators, Ontario Cancer Genetics Network Investigators, Whittemore AS. BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70. Epub 2006 Oct 4.
  39. Haydon AM, MacInnis RJ, English DR, Giles GG. The effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006 Jan;55(1):62-7.
  40. Haydon AM, Macinnis RJ, English DR, Morris H, Giles GG. Physical activity, IGF-1, IGFBP-3 and survival from colorectal cancer. Gut. 2006 May;55(5):689-94.
  41. Hayes VM, Severi G, Southey MC, Padilla EJ, English DR, Hopper JL, Giles GG, Sutherland RL. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1223-5.
  42. Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res. 2006 Feb 15;66(4):2250-6.
  43. Hodge AM, English DR, O'Dea K, Giles GG. Alcohol intake, consumption pattern and beverage type, and the risk of Type 2 diabetes. Diabet Med. 2006 Jun;23(6):690-7.
  44. Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol. 2006 Apr;4(4):489-98.
  45. Jenkins MA, Dharmage SC, Flander LB, Douglass JA, Ugoni AM, Carlin JB, Sawyer SM, Giles GG, Hopper JL. Parity and decreased use of oral contraceptives as predictors of asthma in young women. Clin Exp Allergy. 2006 May;36(5):609-613.
  46. Jenkins MA, Macrae F, Young J, Barker M, Leggett B, Goldblatt J, Kirk J, Tucker K, Suthers G, Young G, Parry S, Arnold J, Winship I, Maskiell J, Giles G, Jass J, Hopper J. The Colon Cancer Family Registry, an international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update 2006;46:14-20
  47. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal ornon-small-cell lung cancer in chemotherapy trials. Intern Med J. 2006 Apr;36(4):216-20.
  48. Johansson H, Bonanni B, Mariette F, Cazzaniga M, Baglietto L, Guerrieri-Gonzaga A, Sandri MT, Luini A, Pelosi G, Decensi A. Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer. Breast Cancer Res Treat. 2006 Jul;98(2):167-72. Epub 2006 Mar 15.
  49. Kang HH, Williams R, Leary J; kConFab Investigators; Ringland C, Kirk J, Ward R. Evaluation of models to predict BRCA germline mutations. Br J Cancer. 2006 Oct 9;95(7):914-20.
  50. Kelsall H, Sim M, McKenzie D, Forbes A, Leder K, Glass D, Ikin J, McFarlane A. Medically evaluated psychological and physical health of Australian Gulf War veterans with chronic fatigue. Journal of Psychosomatic Research 2006; 60:575-584.
  51. Khanjani N, English DR, Sim MR. An ecological study of organochlorine pesticides and breast cancer in rural Victoria, Australia. Archives of Environmental Contamination and Toxicology. Arch Environ Contam Toxicol. 2006 Apr;50(3):452-61. Epub 2006 Feb 17
  52. Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL. An inverse association between ovarian cysts and breast cancer in the breast cancer family registry. Int J Cancer. 2006 Jan 1;118(1):197-202
  53. Lagerlund M, Dixon HG, Simpson JA, Spittal M, Taylor HR, Dobbinson SJ. Observed use of sunglasses in public outdoor settings around Melbourne, Australia: 1993 to 2002. Preventive Medicine. 2006;42:291-6.
  54. Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Variation in the RAD51 gene and familial breast cancer. Breast Cancer Res. 2006;8(3):R26. Epub 2006 Jun 8. PMID: 16762046
  55. Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S, Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ, Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA; kConFab Investigators. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1missense variants. J Med Genet. 2006 Jan;43(1):74-83. Epub 2005 May 27.
  56. MacInnis R, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control 2006 Dec 17(10): 1291-7.
  57. MacInnis R, English DR, Hopper JL, Giles GG. Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer. 2006 May 15;118(10):2628-31.
  58. MacInnis R, English DR. Body size and composition and prostate cancer risk: systematic review and meta regression analysis. Cancer Causes Control. 2006 Oct;17(8):989-1003.
  59. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and colon cancer in postmenopausal women. Int J Cancer. 2006 Mar 15;118(6):1496-500.
  60. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12. Epub 2006 Feb 13.
  61. McGuire V, John EM, Anna Felberg A, Haile RW, Boyd NF,. Thomas DC, Jenkins MA, Milne RL, Daly MB, J Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, kConFab Investigators, Southey M, West DW, Hopper JL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations under age 50 years. Cancer Epidemiol Biomarkers Prev 2006 Aug;15(8):1565-7.
  62. McKenzie DP, McFarlane AC, Creamer M, Ikin JF, Forbes AB, Kelsall HL, Clarke DM, Glass DC, Ittak P, Sim MR. Hazardous or harmful alcohol use in Royal Australian Navy veterans of the 1991 Gulf War: Identification of high risk subgroups. Addictive Behaviors 2006; 31:1683-1694.
  63. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology. 2006;54(5):783-92.
  64. Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG; Urology Study Committee of the Victorian Co-operative Oncology Group. Management of muscle-invasive bladder cancer in Victoria, 1990-1995. ANZ J Surg. 2006 Mar;76(3):113-119.
  65. Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R, English D. R. The impact of the kidskin sun protection intervention on summer suntan and reported sun exposure: Was it sustained? Prev Med. 2006;Jan;42(1):14-20.
  66. Pedeux R, Sales F, Pourchet J, Kallassy M, Fayolle C, Boniol M, Severi G, Ghanem G, Nakazawa H, Autier P, Dore JF. Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma. Eur. J. Cancer 2006;42:212-5.
  67. Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinley JM, Weideman PC, Hopper JL, Friedlander ML; kConFab Investigators. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet. 2006 Sep;70(3):198-206.
  68. Robman L, Vu H, Hodge A, McCarty CA, Taylor HR. Dietary lutein and zeaxanthin: authors' response. Br J Ophthalmol. 2006 Sep;90(9):1211-2.
  69. Rosenthal MA, Drummond KJ, Dally M, Murphy M, Cher L, Ashley D, Thursfield V, Giles GG. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust. 2006 Mar 20;184(6):270-3.
  70. Schaid DJ; Investigators of the International Consortium for Prostate Cancer Genetics. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet. 2006 Nov;120(4):471-85. Epub 2006 Aug 25
  71. Scurrah KJ, Byrnes GB, Hopper JL, Harrap SB. Sex differences in genetic and environmental determinants of pulse pressure. Genet Epidemiol. 2006 Jul;30(5):397-408.
  72. Severi G, English DR, Hopper JL, Giles GG. Prospective Studies of Dairy Product and Calcium Intakes and Prostate Cancer Risk: A Meta-Analysis. J Natl Cancer Inst 2006; 98: 795.
  73. Severi G, Hayes VM, English DR, Hopper JL, Sutherland RL, Giles GG. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):610-2.
  74. Severi G, Hayes VM, Neufing P, Padilla EJD, Tilley W, Eggleton S, Morris H, English D, Southey M, Hopper JL, Sutherland RL, Boyle P, Giles GG. Variants in the Prostate-Specific Antigen (PSA) Gene, and Prostate Cancer Risk, Survival, and Circulating PSA. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1142-7
  75. Severi G, Morris H, MacInnis R, English D, Tilley W, Hopper J, Boyle P, Giles GG. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):86-91.
  76. Severi G, Morris H, MacInnis R, English D, Tilley W, Hopper J, Boyle P, Giles GG. Circulating insulin-like growth factor-1 and binding protein-3 and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.
  77. Siahpush M, English D, Powles J. The contribution of smoking to socio-economic differentials in mortality: Results from the Melbourne Collaborative Cohort Study, Australia. J Epidemiol Community Health. 2006 Dec;60(12):1077-9.
  78. Sim M, Kelsall H. Gulf War illness: a view from Australia. Philosophical Transactions of The Royal Society. 2006;361:619-626.
  79. Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. Br J Clin Pharmacol. 2006; 61(3): 289-300
  80. Smith L, Tesoriero A, Mead L, Royce S, Grubb G, Young J, Giles G, Jenkins M, Macrae F, Hopper JL, Southey MC. Large genomic alterations in hMSH2 and hMLH1 in early onset colorectal cancer: identification of a large complex de novo hMLH1 alteration. Clin Genet 2006: 70: 250-252. (letter to the Editor)
  81. Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, kConFab Investigators, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, Buys S, Andrulis I, Senie R, BCFS, BRCAX Collaborators group, Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JGM, van Asperen C, van Leeuwen I, Vasen HFA, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal PA, Nathanson KL, Weber BL, the Breast Cancer Susceptibility Collaboration (UK), Rahman N, Stratton MR. A Genome Wide Linkage Search For Breast Cancer Susceptibility Genes. Genes Chromosomes Cancer 2006;45:646-655.
  82. Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G; Australian Breast Cancer Family Study, Australian Jewish Breast Cancer Study,Breast Cancer Family Registry, Interdisciplinary Health Research International Team on Breast Cancer Susceptibility, The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, and Epidemiological Study of Familial Breast Cancer Study Collaborators. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):76-9
  83. Staples M, Elwood M, Burton R, Williams J, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006; Jan 2;184(1):6-10
  84. Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):612-7.
  85. Vrijheid M, Cardis E, Armstrong BK, Auvinen A, Berg G, Blaasaas KG, Brown J, Carroll M, Chetrit A, Christensen HC, Deltour I, Feychting M, Giles GG, Hepworth SJ, Hours M, Iavarone I, Johansen C, Klaeboe L, Kurttio P, Lagorio S, Lonn S, McKinney PA, Montestrucq L, Parslow RC, Richardson L, Sadetzki S, Salminen T, Schuz J, Tynes T, Woodward A; Interphone Study Group. Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med. 2006 Apr;63(4):237-43.
  86. Vu HT, Robman L, Hodge A, McCarty CA, Taylor HR. Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3783-6.
  87. Vu HTV, Robman L, McCarty CA, Taylor HR, Hodge A. Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. (Letter) Br J Ophthalmol. 2006; 90:389-90.
  88. Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, Taylor M, Lindeman GJ, Tavtigian SV, Suthers G, Goldgar D, Oefner PJ; kConFab Investigators; Taylor D, Grimmond S, Khanna KK, Chenevix-Trench G. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling. Genes Chromosomes Cancer. 2006 Dec;45(12):1169-81.
  89. Wharton CL, Dharmage SC, Jenkins MA, Dite GS, Giles GG, Abramson MJ, Walters EH, Hopper JL. Tracing 8,600 participants 36 years after recruitment at age 7 for the Tasmanian Asthma Study. Aust N Z J Public Health. 2006 Apr;30(2):105-10.
  90. White V, Pruden M, Giles G, Kitchen P, Collins J, Inglis G, Hill D. Changes in the management of ductal carcinoma in situ before the release of clinical practice recommendations in Australia: the case in Victoria. ANZ J Surg. 2006 Jan;76(1-2):28-34.
  91. Woodward M, Barzi F, Martiniuk A, Fang X, Gu D, Imai Y, Lam T, Pan W, Rodgers A, Suh I, Jee Sh, Ueshima H, Huxley R. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006 Dec 35 (6): 1412-6 Epub 2006. Oct 22.
Email this page to a friend Email this page
Print this page Print friendly


Bookmark and Share

Website Evaluation

Complete our survey
Updated: 20 Dec, 2006